Tailoring Radionuclide Therapy of Neuroendocrine Tumors - Bridging the Gaps

Medicine and Dentistry

• Therapeutic Procedure 100%
• Neuroendocrine Tumor 100%
• Radionuclide Therapy 100%
• Patient 60%
• Dosimetry 50%
• Positron Emission Tomography-Computed Tomography 40%
• Follow up 30%
• Injection 20%
• Therapeutics 10%
• Radiation Oncology 10%
• Kidney Function 10%
• Radioisotope 10%
• Single-Photon Emission Computed Tomography 10%
• Treatment Planning 10%
• Pituitary Gland 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Radioisotope 100%
• Dosimetry 100%
• Lutetium 177 80%
• Neoplasm 40%
• Toxicity 40%
• Clinical Trial 20%
• Observational Study 20%
• Nephrotoxicity 20%
• Phase II Trials 20%
• Insulin-Like Growth Factor 1 20%